Company profilePharmaceutical#542 of 1,318 in Pakistan✓ No DRAP alerts

Pinnacle Biotech (Pvt.) Ltd.

Pharmaceutical company · 23 brands · 21 molecules

23 registered products 22 pharmaceutical brands 21 distinct molecules 0 DRAP alerts

Company overview

23
registered products
22
pharmaceutical brands
21
distinct molecules
0
therapeutic classes
0
DRAP alerts

Pinnacle Biotech (Pvt.) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 23 product registrations across 21 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Pinnacle

18 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

16
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202516

Top molecules by brand count

Pregabalin3 brands
Azithromycin2 brands
Apixaban2 brands
Apixaban ...... 2.5 Mg1 brand
Apixaban ...... 5 Mg1 brand
Rosuvastatin Calcium ...... 5 Mg1 brand
Rosuvastatin Calcium ...... 10 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official32 products · Rs 236.17 – Rs 3,567.94
DVAGO12 products · Rs 210 – Rs 600
Median across source: Rs 596.25

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GETZ PHARMA PAKISTAN (PVT) LTD. holds 269 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
BOSCH PHARMACEUTICALS (PVT) LTD. holds 151 molecules not in this portfolio
AmikacinAmlodipineAmoxicillinAmoxicillin SodiumAmoxicillin …50Mg Clavulanic Acid 12.5 MgAmoxycillin
NABIQASIM INDUSTRIES (PVT) LTD. holds 191 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir

Get the full profile for Pinnacle

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.